Vestal Point Capital, LP
Securities ▲▼ | Shares | Value ($K) | ||||
|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | |
| Revolution Medicines Inc | 295,000 | 2,375,000 | +2,080,000 | 23,496,750 | 230,968,750 | +207,472,000 |
| Neurocrine Biosciences Inc | 0 | 1,250,000 | +1,250,000 | 0 | 164,675,000 | +164,675,000 |
| Repligen Corp | 83,000 | 925,000 | +842,000 | 13,600,380 | 108,983,500 | +95,383,120 |
| Arrowhead Pharmaceuticals Inc | 900,000 | 2,275,000 | +1,375,000 | 59,751,000 | 142,642,500 | +82,891,500 |
| Dyne Therapeutics Inc | 120,000 | 4,000,000 | +3,880,000 | 2,347,200 | 72,520,000 | +70,172,800 |
| Enliven Therapeutics Inc | 3,830,000 | 3,250,000 | -580,000 | 58,982,000 | 127,400,000 | +68,418,000 |
| Sanofi SA | 0 | 1,400,000 | +1,400,000 | 0 | 67,452,000 | +67,452,000 |
| Immunocore Holdings PLC | 585,000 | 2,766,868 | +2,181,868 | 20,305,350 | 83,421,070 | +63,115,720 |
| Apogee Therapeutics Inc | 550,000 | 1,100,000 | +550,000 | 41,514,000 | 92,587,000 | +51,073,000 |
| Boston Scientific Corp | 0 | 800,000 | +800,000 | 0 | 50,200,000 | +50,200,000 |
| BioCryst Pharmaceuticals Inc | 2,250,000 | 7,025,000 | +4,775,000 | 17,550,000 | 66,878,000 | +49,328,000 |
| Ascendis Pharma A/S | 175,000 | 375,000 | +200,000 | 37,317,000 | 85,773,750 | +48,456,750 |
| Bicara Therapeutics Inc | 3,575,000 | 5,425,000 | +1,850,000 | 60,167,250 | 107,903,250 | +47,736,000 |
| Cogent Biosciences Inc | 0 | 1,230,888 | +1,230,888 | 0 | 47,376,879 | +47,376,879 |
| Bristol-Myers Squibb Co | 250,000 | 1,000,000 | +750,000 | 13,485,000 | 60,650,000 | +47,165,000 |
| Monte Rosa Therapeutics Inc | 775,000 | 3,603,465 | +2,828,465 | 12,152,000 | 59,276,999 | +47,124,999 |
| Nuvalent Inc | 46,000 | 481,715 | +435,715 | 4,627,140 | 49,351,702 | +44,724,562 |
| United Therapeutics Corp | 0 | 75,000 | +75,000 | 0 | 44,473,500 | +44,473,500 |
| Bright Minds Biosciences Inc | 0 | 492,319 | +492,319 | 0 | 35,924,517 | +35,924,517 |
| Protagonist Therapeutics Inc | 0 | 326,159 | +326,159 | 0 | 34,377,159 | +34,377,159 |
| Scholar Rock Holding Corp | 700,000 | 1,324,422 | +624,422 | 30,835,000 | 65,108,586 | +34,273,586 |
| Regeneron Pharmaceuticals Inc | 0 | 40,000 | +40,000 | 0 | 30,905,600 | +30,905,600 |
| Waters Corp | 0 | 100,000 | +100,000 | 0 | 29,780,000 | +29,780,000 |
| Viking Therapeutics Inc | 0 | 914,147 | +914,147 | 0 | 29,746,343 | +29,746,343 |
| Inspire Medical Systems Inc | 0 | 539,269 | +539,269 | 0 | 27,815,495 | +27,815,495 |
| Vera Therapeutics Inc | 550,000 | 1,368,159 | +818,159 | 27,852,000 | 55,041,037 | +27,189,037 |
| Denali Therapeutics Inc | 465,000 | 1,773,326 | +1,308,326 | 7,677,150 | 34,047,859 | +26,370,709 |
| Trevi Therapeutics Inc | 0 | 2,166,504 | +2,166,504 | 0 | 25,846,393 | +25,846,393 |
| Soleno Therapeutics Inc | 0 | 730,000 | +730,000 | 0 | 24,440,400 | +24,440,400 |
| BioMarin Pharmaceutical Inc | 3,000,000 | 3,575,000 | +575,000 | 178,290,000 | 201,951,750 | +23,661,750 |
| Nektar Therapeutics | 0 | 285,000 | +285,000 | 0 | 20,505,750 | +20,505,750 |
| Cytokinetics Inc | 0 | 300,000 | +300,000 | 0 | 19,773,000 | +19,773,000 |
| AstraZeneca PLC | 0 | 100,000 | +100,000 | 0 | 19,722,000 | +19,722,000 |
| West Pharmaceutical Services I | 0 | 75,000 | +75,000 | 0 | 18,798,000 | +18,798,000 |
| GE HealthCare Technologies Inc | 0 | 250,000 | +250,000 | 0 | 17,795,000 | +17,795,000 |
| SpyGlass Pharma Inc | 0 | 666,760 | +666,760 | 0 | 17,275,752 | +17,275,752 |
| Madrigal Pharmaceuticals Inc | 0 | 31,468 | +31,468 | 0 | 16,472,554 | +16,472,554 |
| GeneDx Holdings Corp | 0 | 250,000 | +250,000 | 0 | 16,055,000 | +16,055,000 |
| Damora Therapeutics Inc | 0 | 600,000 | +600,000 | 0 | 15,540,000 | +15,540,000 |
| Tarsus Pharmaceuticals Inc | 0 | 200,000 | +200,000 | 0 | 14,030,000 | +14,030,000 |
| Nurix Therapeutics Inc | 4,690,000 | 6,500,000 | +1,810,000 | 88,969,300 | 100,750,000 | +11,780,700 |
| Rapport Therapeutics Inc | 1,110,000 | 1,436,229 | +326,229 | 33,677,400 | 44,939,605 | +11,262,205 |
| Insulet Corp | 0 | 50,601 | +50,601 | 0 | 10,618,114 | +10,618,114 |
| Xenon Pharmaceuticals Inc | 600,000 | 639,900 | +39,900 | 26,892,000 | 37,210,185 | +10,318,185 |
| Surrozen Inc | 0 | 338,611 | +338,611 | 0 | 9,863,738 | +9,863,738 |
| Crescent Biopharma Inc | 1,500,000 | 1,500,000 | 0 | 17,790,000 | 27,555,000 | +9,765,000 |
| Arvinas Inc | 0 | 905,465 | +905,465 | 0 | 9,597,929 | +9,597,929 |
| Celldex Therapeutics Inc | 1,165,000 | 1,224,165 | +59,165 | 31,641,400 | 38,830,514 | +7,189,114 |
| KalVista Pharmaceuticals Inc | 1,890,000 | 1,850,000 | -40,000 | 30,523,500 | 37,240,500 | +6,717,000 |
| Agios Pharmaceuticals Inc | 325,000 | 450,000 | +125,000 | 8,846,500 | 15,223,500 | +6,377,000 |
| Anteris Technologies Global Co | 0 | 1,144,780 | +1,144,780 | 0 | 6,353,529 | +6,353,529 |
| uniQure NV | 0 | 358,996 | +358,996 | 0 | 5,869,585 | +5,869,585 |
| Voyager Therapeutics Inc | 1,475,000 | 3,002,936 | +1,527,936 | 5,796,750 | 11,591,333 | +5,794,583 |
| OnKure Therapeutics Inc | 635,000 | 1,839,819 | +1,204,819 | 1,841,500 | 7,616,851 | +5,775,351 |
| Candel Therapeutics Inc | 0 | 1,125,000 | +1,125,000 | 0 | 5,512,500 | +5,512,500 |
| enGene Therapeutics Inc | 1,055,000 | 2,165,000 | +1,110,000 | 9,526,650 | 14,743,650 | +5,217,000 |
| Taysha Gene Therapies Inc | 13,750,000 | 18,000,000 | +4,250,000 | 75,625,000 | 80,460,000 | +4,835,000 |
| Savara Inc | 1,606,000 | 2,600,052 | +994,052 | 9,684,180 | 14,196,284 | +4,512,104 |
| Palisade Bio Inc | 0 | 2,500,000 | +2,500,000 | 0 | 4,375,000 | +4,375,000 |
| Veracyte Inc | 0 | 130,687 | +130,687 | 0 | 4,209,428 | +4,209,428 |
| Zenas Biopharma Inc | 0 | 200,000 | +200,000 | 0 | 3,910,000 | +3,910,000 |
| Beta Bionics Inc | 600,000 | 2,211,518 | +1,611,518 | 18,282,000 | 22,159,410 | +3,877,410 |
| Zimmer Biomet Holdings Inc | 150,000 | 190,000 | +40,000 | 13,488,000 | 17,179,800 | +3,691,800 |
| Monopar Therapeutics Inc | 0 | 65,418 | +65,418 | 0 | 3,584,252 | +3,584,252 |
| Tectonic Therapeutic Inc | 328,000 | 328,000 | 0 | 6,842,080 | 10,138,480 | +3,296,400 |
| Solid Biosciences Inc | 5,815,000 | 5,000,000 | -815,000 | 32,796,600 | 36,000,000 | +3,203,400 |
| Zura Bio Ltd | 0 | 511,000 | +511,000 | 0 | 3,040,450 | +3,040,450 |
| UroGen Pharma Ltd | 0 | 139,079 | +139,079 | 0 | 2,500,640 | +2,500,640 |
| Alto Neuroscience Inc | 2,485,000 | 2,064,075 | -420,925 | 44,233,000 | 46,400,406 | +2,167,406 |
| MapLight Therapeutics Inc | 385,000 | 420,000 | +35,000 | 6,762,525 | 8,538,600 | +1,776,075 |
| Absci Corp | 0 | 232,219 | +232,219 | 0 | 696,657 | +696,657 |
| REGENXBIO Inc | 34,000 | 108,525 | +74,525 | 489,600 | 909,440 | +419,840 |
| MacroGenics Inc | 280,000 | 280,000 | 0 | 450,800 | 809,200 | +358,400 |
| Aprea Therapeutics Inc | 0 | 350,000 | +350,000 | 0 | 267,015 | +267,015 |
| Tenax Therapeutics Inc | 53,439 | 53,439 | 0 | 651,421 | 854,490 | +203,069 |
| Myriad Genetics Inc | 1,223,000 | 1,648,000 | +425,000 | 7,521,450 | 7,416,000 | -105,450 |
| Alector Inc | 755,000 | 0 | -755,000 | 1,177,800 | 0 | -1,177,800 |
| Passage Bio Inc | 305,000 | 305,000 | 0 | 3,599,000 | 2,394,250 | -1,204,750 |
| Fate Therapeutics Inc | 1,725,000 | 0 | -1,725,000 | 1,694,985 | 0 | -1,694,985 |
| Black Diamond Therapeutics Inc | 870,000 | 0 | -870,000 | 2,114,100 | 0 | -2,114,100 |
| Fulcrum Therapeutics Inc | 950,000 | 1,100,000 | +150,000 | 10,744,500 | 8,437,000 | -2,307,500 |
| Structure Therapeutics Inc | 35,000 | 0 | -35,000 | 2,434,250 | 0 | -2,434,250 |
| Nyxoah SA | 1,107,000 | 868,661 | -238,339 | 5,092,200 | 2,536,490 | -2,555,710 |
| Sutro Biopharma Inc | 243,000 | 0 | -243,000 | 2,811,510 | 0 | -2,811,510 |
| Immatics NV | 6,125,000 | 6,175,000 | +50,000 | 64,312,500 | 60,762,000 | -3,550,500 |
| Rezolute Inc | 1,686,000 | 0 | -1,686,000 | 3,978,960 | 0 | -3,978,960 |
| Novocure Ltd | 525,000 | 250,000 | -275,000 | 6,788,250 | 2,725,000 | -4,063,250 |
| LENZ Therapeutics Inc | 275,000 | 0 | -275,000 | 4,400,000 | 0 | -4,400,000 |
| Mirum Pharmaceuticals Inc | 66,000 | 0 | -66,000 | 5,213,340 | 0 | -5,213,340 |
| DBV Technologies SA | 300,000 | 0 | -300,000 | 5,751,000 | 0 | -5,751,000 |
| Gilead Sciences Inc | 50,000 | 0 | -50,000 | 6,137,000 | 0 | -6,137,000 |
| Definium Therapeutics Inc | 637,000 | 0 | -637,000 | 8,529,430 | 0 | -8,529,430 |
| Geron Corp | 11,320,000 | 2,540,000 | -8,780,000 | 14,942,400 | 3,784,600 | -11,157,800 |
| Disc Medicine Inc | 735,000 | 700,000 | -35,000 | 58,366,350 | 44,758,000 | -13,608,350 |
| Penumbra Inc | 50,000 | 0 | -50,000 | 15,545,500 | 0 | -15,545,500 |
| Lexeo Therapeutics Inc | 4,475,000 | 4,475,000 | 0 | 44,436,750 | 25,686,500 | -18,750,250 |
| Upstream Bio Inc | 720,000 | 0 | -720,000 | 19,548,000 | 0 | -19,548,000 |
| Zymeworks Inc | 865,000 | 0 | -865,000 | 22,775,450 | 0 | -22,775,450 |
| Lantheus Holdings Inc | 360,000 | 0 | -360,000 | 23,958,000 | 0 | -23,958,000 |
| Alcon AG | 1,105,000 | 800,000 | -305,000 | 87,085,050 | 60,280,000 | -26,805,050 |